Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

This study is looking at whether services offered by the Leukemia and Lymphoma Society (LLS) — such as patient support programs, financial assistance, and education resources — improve health outcomes and quality of care for blood cancer patients. **You may be eligible if...** - You have been diagnosed with or have a recurrence of leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN) - You are currently in treatment (started within the past 18 months), plan to start treatment within one month, OR have had a bone marrow transplant or CAR-T cell therapy within the past 100 days - You speak English or Spanish - You are willing to be followed for 6 months **You may NOT be eligible if...** - You are not being treated for one of the listed blood cancers - You are already using LLS programs or services - You are not willing to complete the 6-month follow-up Talk to your doctor to see if this trial is right for you.